Sensory and motor complications of local anesthetics

Muscle and Nerve

Volumn 37, Issue 4, 2008, Pages 421-425

  Gerner, Peter ^a   Strichartz, Gary R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BISULFITE; BUPIVACAINE; CALCIUM; CHLOROPROCAINE; GLUTAMIC ACID; LIDOCAINE; LOCAL ANESTHETIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; TETRACAINE;

CALCIUM CELL LEVEL; EDITORIAL; ENZYME ACTIVATION; HUMAN; INCIDENCE; MOTOR DYSFUNCTION; NERVE FIBER TRANSPORT; NEUROLOGIC DISEASE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SYMPTOM; VASOCONSTRICTION;

ANESTHETICS, LOCAL; HUMANS; INCIDENCE; MOTOR NEURONS; NEURONS, AFFERENT; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYRADICULOPATHY;

EID: 41849110227     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20967     Document Type: Editorial

References (28)

1. Aps C, Reynolds F. The effect of concentration on vasoactivity of bupivacaine and lignocaine. Br J Anaesth 1976;48:1171-1174.
2. Auroy Y, Narchi P, Messiah A, Litt L, Rouvier B, Samii K. Serious complications related to regional anesthesia: results of a prospective survey in France. Anesthesiology 1997;87:479-486.
3. Bainton CR, Strichartz GR. Concentration dependence of lidocaine-induced irreversible conduction loss in frog nerve. Anesthesiology 1994;81:657-667.
4. Benumof JL. Permanent loss of cervical spinal cord function associated with interscalene block performed under general anesthesia. Anesthesiology 2000;93:1541-1544.
5. Borgeat A, Ekatodramis G, Kalberer F, Benz C. Acute and nonacute complications associated with interscalene block and shoulder surgery: a prospective study. Anesthesiology 2001;95:875-880.
6. Cao J, Viholainen JI, Dart C, Warwick HK, Leyland ML, Courtney MJ. The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J Cell Biol 2005;168:117-126.
7. Friederich P, Schmitz TP. Lidocaine-induced cell death in a human model of neuronal apoptosis. Eur J Anaesthesiol 2002;19:564-570.
8. Horlocker TT, McGregor DG, Matsushige DK, Chantigian RC, Schroeder DR, Besse JA. Neurologic complications of 603 consecutive continuous spinal anesthetics using macrocatheter and microcatheter techniques. Perioperative Outcomes Group. Anesth Analg 1997;84:1063-1070.
9. Ji RR, Strichartz G. Cell signaling and the genesis of neuropathic pain. Sci STKE 2004;2004:reE14.
10. Johns RA, Difazio CA, Longnecker DE. Lidocaine constricts or dilates rat arterioles in a dose-dependent manner. Anesthesiology 1985;62:141-144.
11. Johns RA, Seyde WC, Difazio CA, Longnecker DE. Dose-dependent effects of bupivacaine on rat muscle arterioles. Anesthesiology 1986;65:186-191.
12. Johnson ME, Saenz JA, DaSilva AD, Uhl CB, Gores GJ. Effect of local anesthetic on neuronal cytoplasmic calcium and plasma membrane lysis (necrosis) in a cell culture model. Anesthesiology 2002;97:1466-1476.
13. Kalichman MW. Physiologic mechanisms by which local anesthetics may cause injury to nerve and spinal cord. Reg Anesth 1993;18:448-452.
14. Kalichman MW, Powell HC, Reisner LS, Myers RR. The role of 2-chloroprocaine and sodium bisulfite in rat sciatic nerve edema. J Neuropathol Exp Neurol 1986;45:566-575.
15. Kitagawa N, Oda M, Totoki T. Possible mechanism of irreversible nerve injury caused by local anesthetics: detergent properties of local anesthetics and membrane disruption. Anesthesiology 2004;100:962-967.
16. Lambert IA, Lambert DH, Strichartz GR. Irreversible conduction block in isolated nerve by high concentrations of local anesthetics. Anesthesiology 1994;80:1082-1093.
17. Lirk P, Haller I, Myers RR, Klimaschewski L, Kau YC, Hung YC, et al. Mitigation of direct neurotoxic effects of lidocaine and amitriptyline by inhibition of p38 mitogen-activated protein kinase in vitro and in vivo. Anesthesiology 2006;104:1266-1273.
18. Loo CC, Irestedt L. Cauda equina syndrome after spinal anaesthesia with hyperbaric 5% lignocaine: a review of six cases of cauda equina syndrome reported to the Swedish Pharmaceutical Insurance 1993-1997. Acta Anaesthesiol Scand 1999;43:371-379.
19. Myers RR, Kalichman MW, Reisner LS, Powell HC. Neurotoxicity of local anesthetics: altered perineurial permeability, edema, and nerve fiber injury. Anesthesiology 1986;64:29-35.
20. Myers RR, Yamamoto T, Yaksh TL, Powell HC. The role of focal nerve ischemia and Wallerian degeneration in peripheral nerve injury producing hyperesthesia. Anesthesiology 1993;78:308-316.
21. Neal JM. Effects of epinephrine in local anesthetics on the central and peripheral nervous systems: neurotoxicity and neural blood flow. Reg Anesth Pain Med 2003;28:124-134.
22. Ohtake K, Matsumoto M, Wakamatsu H, Kawai K, Nakakimura K, Sakabe T. Glutamate release and neuronal injury after intrathecal injection of local anesthetics. Neuroreport 2000;11:1105-1109.
23. Rigler ML, Drasner K, Krejcie TC, Yelich SJ, Scholnick FT, DeFontes J, et al. Cauda equina syndrome after continuous spinal anesthesia. Anesth Analg 1991;72:275-281.
24. Tan Z, Dohi S, Chen J, Banno Y, Nozawa Y. Involvement of the mitogen-activated protein kinase family in tetracaine-induced PC12 cell death. Anesthesiology 2002;96:1191-1201.
25. Traore M, Diallo A, Coulibaly Y, Guinto CO, Timbo SK, Thomas JT. Cauda equina syndrome and profound hearing loss after spinal anesthesia with isobaric bupivacaine. Anesth Analg 2006;102:1863-1864.
26. Wang BC, Hillman DE, Spielholz NI, Turndorf H. Chronic neurological deficits and Nesacaine-CE - an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984;63:445-447.
27. Werdehausen R, Braun S, Essmann F, Schulze-Osthoff K, Walczak H, Lipfert P, et al. lidocaine induces apoptosis via the mitochondrial pathway independently of death receptor signaling. Anesthesiology 2007;107:136-143.
28. 2+ regulation: potential mechanisms of its myotoxicity. Anesthesiology 2002;97:710-716.